首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

JOURNAL OF CONTROLLED RELEASE
ISSN：0168-3659

JOURNAL OF CONTROLLED RELEASE

J CONTROL RELEASE
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：约2.6个月
新锐分区：医学1区
年发文量：741
影响因子：11.5
JCR分区：Q1

基本信息

Journal of Controlled Release (JCR) 在广泛的递送科学和技术领域发表高质量的研究文章。这包括药物递送系统和制剂的所有方面，例如药物的物理化学和生物学特性、剂型的设计和表征、释放机制、体内测试以及制药、诊断、农业、环境学科中的制剂研发、化妆品和食品行业。优先考虑推进对原理的基本理解和/或展示新技术在安全性和有效性方面优于当前临床标准的优势的手稿。每期都有封面故事，突出了该期发表的选定文章的重要性。在每个季度末，JCR 编辑会从已发表的研究文章中选出“编辑之选”。
0168-3659SCIE/Scopus收录
11.5
点击查看最新影响趋势>
11.8
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学1区
CHEMISTRY, MULTIDISCIPLINARY 化学：综合
1区
PHARMACOLOGY & PHARMACY 药学
1区
是
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CHEMISTRY, MULTIDISCIPLINARY
SCIE
Q1
25/239
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
12/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CHEMISTRY, MULTIDISCIPLINARY
SCIE
Q1
18/241
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
12/353
237
741
点击查看年发文量趋势图>
19%50约2.6个月-医学-化学综合
5.2%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
90.55%18.05%0.56%
CiteScore：19.40
SJR：2.470
SNIP：1.680
学科类别分区排名百分位
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Pharmaceutical Science
Q1
4 / 185

期刊高被引文献

Drying technology strategies for colon‐targeted oral delivery of biopharmaceuticals
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.023
Understanding structure‐activity relationships of pH‐sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.001
Modulating the antibody density changes the uptake and transport at the blood‐brain barrier of both transferrin receptor‐targeted gold nanoparticles and liposomal cargo
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.005
Recent advances in topical delivery of flavonoids: A review
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.029
MicroRNA delivery through nanoparticles
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.10.007
New insights into designing hybrid nanoparticles for lung cancer: Diagnosis and treatment
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.009
Pulmonary delivery by exploiting doxorubicin and cisplatin co‐loaded nanoparticles for metastatic lung cancer therapy
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.013
Two‐dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.02.015
Controlled release strategy designed for intravitreal protein delivery to the retina
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.11.012
cRGD‐decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.03.005
Glycosaminoglycan-based biomaterials for growth factor and cytokine delivery: Making the right choices
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.10.018
Aligned microchannel polymer‐nanotube composites for peripheral nerve regeneration: Small molecule drug delivery
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.013
Immunomodulatory properties of MSC‐derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.02.032
Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.048
Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.017
Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug‐light intervals
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.030
Ultrasound‐activated microbubbles as a novel intracellular drug delivery system for urinary tract infection
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.03.017
Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.004
Intestinal iontophoresis from mucoadhesive patches: a strategy for oral delivery
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.037
Poly(ethylene glycol)‐block‐poly(d,l‐lactic acid) micelles containing oligo(lactic acid)8‐paclitaxel prodrug: In Vivo conversion and antitumor efficacy
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.02.017
Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.046
A nanoliter resolution implantable micropump for murine inner ear drug delivery
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.032
pH‐sensitive Eudragit® L 100 nanoparticles promote cutaneous penetration and drug release on the skin
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.045
Functional assessment of peptide‐modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.036
Hierarchical tumor acidity‐responsive self‐assembled magnetic nanotheranostics for bimodal bioimaging and photodynamic therapy
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.03.019
Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.018
Stimulating brain recovery after stroke using theranostic albumin nanocarriers loaded with nerve growth factor in combination therapy
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.11.017
A nano‐complex system to overcome antagonistic photo‐chemo combination cancer therapy
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.043
Ulcerative colitis‐specific delivery of keratinocyte growth factor by neutrophils‐simulated liposomes facilitates the morphologic and functional recovery of the damaged colon through alleviating the inflammation
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.02.034
Antimicrobial synergy of monolaurin lipid nanocapsules with adsorbed antimicrobial peptides against Staphylococcus aureus biofilms in vitro is absent in vivo
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.11.018
Thermosensitive nanocomposite gel for intra‐tumoral two‐photon photodynamic therapy
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.019
Liposomal dexamethasone inhibits tumor growth in an advanced human‐mouse hybrid model of multiple myeloma
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.028
Modular core‐shell polymeric nanoparticles mimicking viral structures for vaccination
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.11.006
Microfluidic assembly of hydrogel‐based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.010
Novel auristatin E‐based albumin‐binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.010
Synchronous delivery of hydroxyapatite and connective tissue growth factor derived osteoinductive peptide enhanced osteogenesis
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.02.037
pH‐Sensitive morphological transitions in polymeric tadpole assemblies for programmed tumor therapy
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.10.033
Polymeric nanobiotics as a novel treatment for mycobacterial infections
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.10.009
Oligodepsipeptide (nano)carriers: Computational design and analysis of enhanced drug loading
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.03.004
PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.02.008
Smart triblock dendritic unimolecular micelles as pioneering nanomaterials: Advancement pertaining to architecture and biomedical applications
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.02.026
Nanohybrids – cancer theranostics for tiny tumor clusters
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.02.027
Glatiramer acetate persists at the injection site and draining lymph nodes via electrostatically‐induced aggregation
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.11.007
Silica cloaking of adenovirus enhances gene delivery while reducing immunogenicity
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.01.034
Radiolabeling of cell membrane‐based nano‐vesicles with 14C‐linoleic acid for robust and sensitive quantification of their biodistribution
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.005
A preclinical evaluation of a programmable CNT membrane device for transdermal nicotine delivery in hairless Guinea pigs
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.07.003
The antifibrotic potential of a sustained release formulation of a PDGF&bgr;‐receptor targeted rho kinase inhibitor
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.039
Sequential activation of anticancer therapy triggered by tumor microenvironment‐selective imaging
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2019.02.012
Anti‐tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high‐expressive prostate cancer PC‐3M cells
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.034
Sequestering and inhibiting a vascular endothelial growth factor in vivo by systemic administration of a synthetic polymer nanoparticle
来源期刊：Journal of Controlled ReleaseDOI：10.1016/j.jconrel.2018.12.033

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

Acta Biomaterialia封面

Acta Biomaterialia

学科领域：医学
影响因子：9.6
中科院分区： 1区
ACTA PHARMACOLOGICA SINICA封面

ACTA PHARMACOLOGICA SINICA

学科领域：医学
影响因子：8.4
中科院分区： 1区
ADVANCED DRUG DELIVERY REVIEWS封面

ADVANCED DRUG DELIVERY REVIEWS

学科领域：医学
影响因子：17.6
中科院分区： 1区
AGEING RESEARCH REVIEWS封面

AGEING RESEARCH REVIEWS

学科领域：医学
影响因子：12.4
中科院分区： 1区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布
大类学科小类学科Top期刊综述期刊
医学1区
CHEMISTRY, MULTIDISCIPLINARY 化学：综合
1区
PHARMACOLOGY & PHARMACY 药学
1区
是
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学1区
PHARMACOLOGY & PHARMACY 药学
1区
CHEMISTRY, MULTIDISCIPLINARY 化学：综合
2区
是
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学1区
CHEMISTRY, MULTIDISCIPLINARY 化学：综合
1区
PHARMACOLOGY & PHARMACY 药学
1区
是
否